Overview

Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to demonstrate that Rotigotine transdermal patch is efficacious in Chinese subjects with advanced-stage Idiopathic Parkinson's Disease as an adjuvant therapy.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Pharma
Collaborator:
UCB Trading (Shanghai) Co. Ltd.
Treatments:
Levodopa
N 0437
Rotigotine